8 patents
Utility
Methods and Compounds for the Treatment of Fragile X
14 Sep 23
The present disclosure relates to compounds and methods which may be useful for modulating the expression of a target gene comprising a CGG trinucleotide repeat sequence and treating diseases and conditions in which the target gene plays an active role.
Aseem ANSARI, Sean J. JEFFRIES, Pratik SHAH, Chengzhi ZHANG
Filed: 8 Jan 21
Utility
Methods and Compounds for the Treatment of Genetic Disease
14 Sep 23
The present disclosure relates to compounds and methods for modulating the expression of bean (brain expressed, associated with NEDD4) and treating diseases and conditions in which bean plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 26 Sep 22
Utility
Methods and Compounds for the Treatment of Genetic Disease
18 May 23
The present disclosure relates to compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role.
Aseem ANSARI, Sean J. JEFFRIES, Pratik SHAH, Chengzhi ZHANG
Filed: 3 Feb 21
Utility
Methods and Compounds for the Treatment of Genetic Disease
16 Feb 23
The present disclosure relates to compounds and methods which may be useful for modulating the expression of a target gene comprising a CGG trinucleotide repeat sequence and treating diseases and conditions in which the target gene plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 2 Jul 19
Utility
Methods and Compounds for the Treatment of Genetic Disease
16 Sep 21
The present disclosure relates to compounds and methods for modulating the expression of bean (brain expressed, associated with NEDD4) and treating diseases and conditions in which bean plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 19 Apr 19
Utility
Methods and Compounds for the Treatment of Genetic Disease
16 Sep 21
The present disclosure relates to compounds and methods for modulating the expression ofc9orf72 (brain expressed, associated with NEDD4) and treating diseases and conditions in which c9orf72 plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 9 May 19
Utility
Methods and Compounds for the Treatment of Genetic Disease
5 Aug 21
The present disclosure relates to compounds and methods for modulating the expression of dmpk, atxn1, atxn2, atxn3, cacna1a, atxn7, ppp2r2br tbp, htt, jph3r ar, or atn1 and treating diseases and conditions in which dmpk, atxn1, atxn2, atxn3, cacna1a, atxn1, ppp2r2b, tbp, htt, jph3, ar, or atn1 plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 22 May 19
Utility
Methods and Compounds for the Treatment of Genetic Disease
29 Jul 21
The present disclosure relates to compounds and methods which may be useful for modulating the expression of fxn and treating diseases and conditions in which fxn plays an active role.
Aseem ANSARI, Pratik SHAH
Filed: 22 May 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first